Recombinant Human N-myc proto-oncogene protein (MYCN)

Recombinant Human N-myc proto-oncogene protein (MYCN) — recombinant protein from Homo sapiens (Human), expressed in Yeast. Purity >85%.

SKU: BCRECP-001205 Category:

Product Specifications

Product SkuBCRECP-001205
Product DescriptionRecombinant Human N-myc proto-oncogene protein (MYCN) Protein is expressed from Yeast with C-terminal DEEP1-tagged. It contains 1-464aa. [Accession | P04198].
Uniprot No.P04198
Gene NamesMYCN
PurityGreater than 85% as determined by SDS-PAGE.
Expression SystemYeast
Expression Region1-464aa
SpeciesHomo sapiens (Human)
Tag InfoC-terminal DEEP1-tagged
Molecular weight61.7kDa
ActivityPlease contact us to obtain bioactivity data.
BufferIf the delivery form is liquid, the default storage buffer is Tris/PBS-based buffer, 5%-50% glycerol. If the delivery form is lyophilized powder, the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose.
StorageStore at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.
Research AreasCancer

Function

Positively regulates the transcription of MYCNOS in neuroblastoma cells.

Biological Context

Subcellular Location: Nucleus
Tissue Specificity: Expressed in the neuronal cells of the cerebrum, neuroblastomas and thyroid tumors (at protein level)
Disease Association: [Amplification of the N-MYC gene is associated with a variety of human tumors, most frequently neuroblastoma, where the level of amplification appears to increase as the tumor progresses] | Feingold syndrome 1 (FGLDS1) : A syndrome characterized by variable combinations of esophageal and duodenal atresias, microcephaly, learning disability, intellectual disability, and limb malformations. Hand and foot abnormalities may include hypoplastic thumbs, clinodactyly of second and fifth fingers, syndactyly (characteristically between second and third and fourth and fifth toes), and shortened or absent middle phalanges. Cardiac and renal malformations, vertebral anomalies, and deafness have also been described. [The disease is caused by variants affecting the gene represented in this entry] | Megalencephaly-polydactyly syndrome (MPAPA) : An autosomal dominant syndrome characterized by megalencephaly, ventriculomegaly, postaxial polydactyly, and increased risk of neuroblastoma. [The disease is caused by variants affecting the gene represented in this entry]

Product Specifications

Recombinant Human N-myc proto-oncogene protein (MYCN) is a recombinant protein from Homo sapiens (Human), expressed in Yeast, covering amino acids 1-464aa, with C-terminal DEEP1-tagged tag, molecular weight 61.7kDa, purity Greater than 85% as determined by SDS-PAGE.. Suitable for ELISA and Western Blot applications.

Recommended applications depend on the target, product format, and product-specific validation data. Refer to the product datasheet or Certificate of Analysis (CoA), or contact BioCrest Sci for application guidance.

Biological Activity: Please contact us to obtain bioactivity data.

Storage: Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use. Avoid repeated freeze-thaw cycles.

Shipping & Lead Time: Availability, shipping conditions, and estimated lead time are confirmed in the formal quotation or order confirmation based on the product format, destination, and order requirements.

Protein Biology

Function

Positively regulates the transcription of MYCNOS in neuroblastoma cells

Subcellular Location

Nucleus

Disease Association

[Amplification of the N-MYC gene is associated with a variety of human tumors, most frequently neuroblastoma, where the level of amplification appears to increase as the tumor progresses] | Feingold syndrome 1 (FGLDS1) : A syndrome characterized by variable combinations of esophageal and duodenal atresias, microcephaly, learning disability, intellectual disability, and limb malformations. Hand and foot abnormalities may include hypoplastic thumbs, clinodactyly of second and fifth fingers, syndactyly (characteristically between second and third and fourth and fifth toes), and shortened or absent middle phalanges. Cardiac and renal malformations, vertebral anomalies, and deafness have also been described. [The disease is caused by variants affecting the gene represented in this entry] | Megalencephaly-polydactyly syndrome (MPAPA) : An autosomal dominant syndrome characterized by megalencephaly, ventriculomegaly, postaxial polydactyly, and increased risk of neuroblastoma. [The disease is caused by variants affecting the gene represented in this entry]

Tissue Specificity

Expressed in the neuronal cells of the cerebrum, neuroblastomas and thyroid tumors (at protein level)

Subunit

Efficient DNA binding requires dimerization with another bHLH protein. Binds DNA as a heterodimer with MAX. Interacts with KDM5A, KDM5B and HUWE1. Interacts with MYCNOS. Interacts with AURKA; interaction is phospho-independent and triggers AURKA activation; AURKA competes with FBXW7 for binding to unphosphorylated MYCN but not for binding to unphosphorylated MYCN (PubMed:27837025). Interacts with FBXW7; FBXW7 competes with AURKA for binding to unphosphorylated MYCN but not for binding to phosphorylated MYCN (PubMed:27837025)

Gene: MYCN  |  Organism: Homo sapiens  |  Synonyms: Class E basic helix-loop-helix protein 37
Key Publications

Frequently Asked Questions

How do I order or inquire about this product?

Submit the Online Inquiry form with your required quantity and specifications, or email sales@biocrestsci.com. Available sizes, pricing, stock status, documentation, and estimated lead time are confirmed in the formal quotation.

What is the shipping and delivery time?

Availability, dispatch timing, shipping conditions, and delivery estimates depend on the product format, destination, and order requirements. These details are confirmed in the formal quotation or order confirmation.

How should this product be stored?

Follow the storage and handling instructions in the product-specific datasheet and Certificate of Analysis (CoA). Requirements may vary by product form and formulation; contact BioCrest Sci if product-specific guidance is needed.

What quality controls are performed on your products?

Quality-control data such as identity, purity, endotoxin level, or biological activity are provided only when specified on this product page, the datasheet, or Certificate of Analysis (CoA). Biological activity is not implied unless explicitly stated.

Shopping Cart
Scroll to Top